Guy Toner

Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up

Ciara Conduit, Thuan Tzen Koh, Michael S Hofman, Guy C Toner, Jeremy Goad, Nathan Lawrentschuk, Keen-Hun Tai, Jeremy H Lewin, Ben Tran

Journal article  |  2022  |  CANCER IMAGING

BACKGROUND: Survivors of testicular cancer may experience long-term morbidity following treatment. There is an unmet need to inves..

High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centres

Elizabeth A Connolly, Andrew Weickhardt, Peter Grimison, Rebecca Asher, Gillian Z Heller, Jeremy Lewin, Elizabeth Liow, Guy Toner, Iris LY Tung, Ben Tran, Sean Hill, Euan Walpole, Jane McKenzie, Anna Kuchel, Jeffrey Goh, Garry Forgeson, Alvin Tan, Abhishek Joshi, Alistair Wickham, Hsiang Tan, et al.

Journal article  |  2022  |  BJU INTERNATIONAL

OBJECTIVE: To report treatment patterns and survival outcomes of patients with relapsed and refractory metastatic germ cell tumour..

Exploring the role for FDG-PET/CT in testicular seminoma at diagnosis and during active surveillance across the disease spectrum

Ciara Conduit, Thuan Tzen Koh, Michael F Hofman, Jeremy H Lewin, Guy Toner, Ben Tran

Conference Proceedings  |  2021  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Clinical utility of FDG PET-CT in stage 1 and advanced testicular seminoma.

Ciara Conduit, Michael S Hofman, Jeremy Howard Lewin, Guy C Toner, Ben Tran

Journal article  |  2021  |  JOURNAL OF CLINICAL ONCOLOGY

5027 Background: Testicular seminoma is highly curable; however, treatments can cause long-term morbidity in survivors. Following..

P3BEP (ANZUP 1302): An international randomized phase III trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumors (GCTs).

Shalini Subramaniam, Guy C Toner, Martin R Stockler, Andrew James Martin, Farzana D Pashankar, Ben Tran, Mark Jeffery, Danish Mazhar, Robert A Huddart, Euan Thomas Walpole, Amanda Gwendolyn Stevanovic, David Wyld, Fritha J Hanning, Matthew James Wheater, Jay R Balagtas, Simon Troon, Alison Jane Birtle, Jeff D White, Peter S Grimison

Conference Proceedings  |  2021  |  JOURNAL OF CLINICAL ONCOLOGY

TPS390 Background: Bleomycin, etoposide, and cisplatin (BEP) given 3-weekly x 4 is standard first-line chemotherapy for metastati..

Denosumab and pembrolizumab in clear cell renal carcinoma (KEYPAD): A phase II trial (ANZUP1601).

Craig Gedye, Abhishek Jagdish Joshi, Alison Yan Zhang, Andrew James Martin, Anthony M Joshua, Carole A Harris, Craig Underhill, David William Pook, Guy C Toner, Ganessan Kichenadasse, Jane Yeojeong So, Jeffrey C Goh, Michelle Frances Morris, Nicola Jane Lawrence, Tom Ferguson, Paul Austin Vasey, Prashanth Prithviraj, Shalini Subramaniam, Martin R Stockler, Ian D Davis

Conference Proceedings  |  2021  |  JOURNAL OF CLINICAL ONCOLOGY

TPS367 Background: Inhibitors of the programmed death-1 pathway (PD-1) are effective in clear cell renal cell cancer (ccRCC). Pre..

P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs)

Shalini Subramaniam, Guy C Toner, Martin R Stockler, Andrew Martin, Farzana Pashankar, Ben Tran, Mark Jeffery, Danish Mazhar, Robert Huddart, Euan Walpole, Amanda G Stevanovic, David Wyld, Fritha J Hanning, Matthew Wheater, Jay M Balagtas, Simon Troon, Alison Birtle, Jeffery White, Peter S Grimison

Conference Proceedings  |  2020  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Outcomes of high dose chemotherapy and stem cell transplantation for relapsed or refractory germ cell tumours from 1999-2019. An Australia and New Zealand (ANZ). registry-based study in collaboration with ABMTRR.

Liz Connolly, Andrew Weickhardt, Peter Grimison, Rebecca Asher, Gillian Hellier, Jeremy Lewin, Elizabeth Liow, Guy Toner, Iris Tung, Ben Tran, Sean Hill, Anna Kuchel, Euan Walpole, Jane Mckenzie, Jeffrey Goh, Garry Forgeson, Alvin Tan, Abhishek Joshi, Alistair Wickham, Hsiang Tan, et al.

Conference Proceedings  |  2020  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Pulmonary function testing for the early detection of drug-induced lung disease: a systematic review in adults treated with drugs associated with pulmonary toxicity

Allan Bui, Sangjin Han, Marliese Alexander, Guy Toner, Lou Irving, Renee Manser

Journal article  |  2020  |  INTERNAL MEDICINE JOURNAL

Pulmonary function tests (PFT) are sometimes monitored during treatment with known pulmonary toxic drugs to detect asymptomatic dr..

P3BEP (ANZUP 1302): An international randomized phase III trial of accelerated versus standard BEP chemotherapy for adult and pediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs).

Shalini Subramaniam, Guy C Toner, Martin R Stockler, Andrew James Martin, Farzana D Pashankar, A Lindsay Frazier, Danish Mazhar, Kate Ford, Euan Thomas Walpole, Amanda Gwendolyn Stevanovic, David Wyld, Simon Troon, Fritha J Hanning, Alison Jane Birtle, Matthew James Wheater, Robert A Huddart, Jeff D White, Sheri L Spunt, Peter S Grimison

Journal article  |  2020  |  Journal of Clinical Oncology

TPS425 Background: Bleomycin, etoposide, cisplatin (BEP) given 3-weekly x 4 remains standard 1st line chemotherapy for metastatic..